ES2582309T3 - Uso de trinitrato de glicerilo para el tratamiento de edema traumático - Google Patents

Uso de trinitrato de glicerilo para el tratamiento de edema traumático

Info

Publication number
ES2582309T3
ES2582309T3 ES11748571.4T ES11748571T ES2582309T3 ES 2582309 T3 ES2582309 T3 ES 2582309T3 ES 11748571 T ES11748571 T ES 11748571T ES 2582309 T3 ES2582309 T3 ES 2582309T3
Authority
ES
Spain
Prior art keywords
treatment
glyceryl trinitrate
traumatic edema
traumatic
edema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11748571.4T
Other languages
English (en)
Inventor
Marianne Boskamp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
G Pohl Boskamp GmbH and Co KG
Original Assignee
G Pohl Boskamp GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G Pohl Boskamp GmbH and Co KG filed Critical G Pohl Boskamp GmbH and Co KG
Application granted granted Critical
Publication of ES2582309T3 publication Critical patent/ES2582309T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Trinitrato de glicerilo (GTN) para su uso en el tratamiento del edema traumático, en donde el edema traumático se caracteriza por la aparición temporal de las condiciones de hinchazón después de fracturas óseas, contusiones, esguinces, luxaciones, impactos, golpes o caídas, en donde el edema traumático no es linfidema postraumático secundario, y en donde se aplica por vía tópica el trinitrato de glicerilo (GTN).

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9

Claims (1)

  1. imagen1
ES11748571.4T 2010-08-03 2011-08-03 Uso de trinitrato de glicerilo para el tratamiento de edema traumático Active ES2582309T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102010033182 2010-08-03
DE102010033182 2010-08-03
PCT/EP2011/003890 WO2012016691A1 (en) 2010-08-03 2011-08-03 Use of glyceryl trinitrate for treating traumatic edema

Publications (1)

Publication Number Publication Date
ES2582309T3 true ES2582309T3 (es) 2016-09-12

Family

ID=44509174

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11748571.4T Active ES2582309T3 (es) 2010-08-03 2011-08-03 Uso de trinitrato de glicerilo para el tratamiento de edema traumático

Country Status (7)

Country Link
US (3) US20130121930A1 (es)
EP (3) EP2600837A1 (es)
AU (1) AU2011287948B2 (es)
CA (1) CA2806636C (es)
ES (1) ES2582309T3 (es)
PL (1) PL2467128T3 (es)
WO (2) WO2012016690A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2600837A1 (en) * 2010-08-03 2013-06-12 G. Pohl-Boskamp GmbH & Co. KG Use of glyceryl trinitrate for treating hematomas
PL2668947T3 (pl) 2012-05-31 2017-06-30 G. Pohl-Boskamp Gmbh & Co. Kg Indukcja arteriogenezy donorem NO, takim jak nitrogliceryna
AT513312A1 (de) * 2012-08-17 2014-03-15 Gebro Holding Gmbh Antiseptische Zusammensetzung
WO2014193804A1 (en) * 2013-05-28 2014-12-04 Biogen Idec Ma Inc. Method of assessing risk of pml
JP6951074B2 (ja) * 2014-03-28 2021-10-20 エス．シー． ジョンソン アンド サン、インコーポレイテッド ポンプの濃縮空気清浄剤
GB2592376A (en) * 2020-02-25 2021-09-01 Aer Beatha Ltd Canister

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632504A (es) 1962-05-24
GB1205019A (en) 1966-12-07 1970-09-09 Sterwin Ag Improvements in or relating to oral dosage forms
JPS599539B2 (ja) 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
CA1163195A (en) 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
US4542013A (en) 1981-07-08 1985-09-17 Key Pharmaceuticals, Inc. Trinitroglycerol sustained release vehicles and preparation therefrom
DE3246081A1 (de) 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
EP0583821B1 (en) 1987-01-23 2000-03-29 The General Hospital Corporation Hydralazine as topical treatment for glaucoma
JPH0645538B2 (ja) * 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
HU199678B (en) 1988-07-08 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing aerosols containing nitroglicerol
DE4007705C1 (es) 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
DE4018919C2 (de) * 1990-06-13 1994-08-25 Sanol Arznei Schwarz Gmbh Nitroglycerin-Spray
US5370862A (en) 1990-06-13 1994-12-06 Schwarz Pharma Ag Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
DE4026072A1 (de) 1990-08-17 1992-02-20 Sanol Arznei Schwarz Gmbh Nitroglycerinhaltiger, hydrophiler, waessriger pumpspray
DE4038203A1 (de) * 1990-11-30 1992-06-04 Kali Chemie Pharma Gmbh Pharmazeutische spray-zubereitungen mit coronaraktiven wirkstoffen
US5698589A (en) 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5869082A (en) 1996-04-12 1999-02-09 Flemington Pharmaceutical Corp. Buccal, non-polar spray for nitroglycerin
US20010044584A1 (en) 1997-08-28 2001-11-22 Kensey Kenneth R. In vivo delivery methods and compositions
US20030095925A1 (en) 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
DE69802832T2 (de) 1997-10-03 2002-06-20 Warner Lambert Co Gepresste nitroglycerintablette und verfahren zu ihrer herstellung
US6796966B2 (en) 1997-10-15 2004-09-28 Jeffrey E. Thomas Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal
AU2479099A (en) 1998-01-28 1999-08-16 Seatrace Pharmaceuticals, Inc. Topical vasodilatory gel composition and methods of use and production
US5989529A (en) * 1998-11-20 1999-11-23 Schering-Plough Healthcare Products, Inc. Substantive topical composition
IT1303793B1 (it) 1998-11-27 2001-02-23 Promefarm S R L "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
US6962691B1 (en) 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
RU2174838C2 (ru) * 1999-11-04 2001-10-20 Ивановская государственная медицинская академия Способ лечения тяжелого бронхообструктивного синдрома у детей раннего возраста
AU2727701A (en) 1999-12-15 2001-06-25 Cellegy Pharmaceuticals, Inc. Nitroglycerin ointment for treatment of pain associated with anal disease
US6443307B1 (en) 2000-01-25 2002-09-03 Michael D. Burridge Medication dispenser with an internal ejector
US20010048987A1 (en) 2000-03-14 2001-12-06 David Kanios Packaging materials for transdermal drug delivery systems
US6538033B2 (en) 2000-08-29 2003-03-25 Huntington Medical Research Institutes Nitric oxide donor compounds
ATE480226T1 (de) 2001-06-22 2010-09-15 Bend Res Inc Pharmazeutische zusammensetzung enthaltend schwer lösliche und säureempfindliche arzneistoffe und neutralisierte anionische polymere
PL202643B1 (pl) 2002-02-08 2009-07-31 Procter & Gamble Saszetka trzyszwowa do ciekłego lub proszkowego wyrobu medycznego
US20050095278A1 (en) 2003-01-14 2005-05-05 Viorel Nicolaescu Use of nitroglycerin to relieve nocturnal muscle cramps
US20040228883A1 (en) 2003-02-21 2004-11-18 Mitchell Karl Prepackaged aqueous pharmaceutical formulation for the treatment of cardiac conditions containing at least two different active agents and method of formulation
WO2005004989A2 (en) 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
US20070053966A1 (en) * 2003-10-17 2007-03-08 Robert Ang Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
US7781226B2 (en) 2004-02-27 2010-08-24 The Board Of Regents Of The University Of Texas System Particle on membrane assay system
CA2557814A1 (en) 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
US20080260861A1 (en) * 2004-04-07 2008-10-23 The General Hospital Corporation Modulating Lymphatic Function
CA2636638C (en) 2006-01-09 2014-02-18 Pantarhei Bioscience B.V. A method of treating an acute vascular disorder
CA2649895C (en) 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
US20080193385A1 (en) * 2007-02-08 2008-08-14 Todd Maibach Compositions and methods for treating neuropathy
US10406118B2 (en) 2007-02-26 2019-09-10 Jon Lundberg Use of nitrites and nitrates and compositions containing these
CN101229148A (zh) 2007-12-28 2008-07-30 天津医科大学 硝酸甘油口腔(舌下)崩解片的制剂及其制备方法
DE102008005484A1 (de) 2008-01-22 2009-07-23 Schaper, Wolfgang, Dr. Induktion und Förderung der Arteriogenese
PL2098249T3 (pl) 2008-03-05 2013-03-29 Rivopharm Sa Nośniki o zwiększonej trwałości dla nikorandylu
US20100184870A1 (en) * 2008-03-14 2010-07-22 Rolf Groteluschen Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate
DE202008007318U1 (de) 2008-03-14 2008-07-31 G. Pohl-Boskamp Gmbh & Co. Kg Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat
WO2010011650A1 (en) * 2008-07-21 2010-01-28 Imi International Medical Innovations (D/B/A Procris Pharmaceuticals) Stable water-based topical pharmaceutical creams and methods of making and using same
CA3130908A1 (en) 2009-06-30 2010-12-30 Mallinckrodt Hospital Products IP Limited Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
EP2600837A1 (en) * 2010-08-03 2013-06-12 G. Pohl-Boskamp GmbH & Co. KG Use of glyceryl trinitrate for treating hematomas

Also Published As

Publication number Publication date
US9180109B2 (en) 2015-11-10
EP2600837A1 (en) 2013-06-12
US20130129638A1 (en) 2013-05-23
WO2012016690A1 (en) 2012-02-09
EP2467128A1 (en) 2012-06-27
PL2467128T3 (pl) 2016-10-31
AU2011287948B2 (en) 2014-11-06
CA2806636C (en) 2018-01-23
CA2806636A1 (en) 2012-02-09
WO2012016691A1 (en) 2012-02-09
US20160213637A1 (en) 2016-07-28
US9693983B2 (en) 2017-07-04
AU2011287948A1 (en) 2013-02-07
US20130121930A1 (en) 2013-05-16
EP2990032A1 (en) 2016-03-02
EP2467128B1 (en) 2016-04-13

Similar Documents

Publication Publication Date Title
ES2582309T3 (es) Uso de trinitrato de glicerilo para el tratamiento de edema traumático
ES2496092T3 (es) El uso de amisulprida para tratar náuseas y vómitos posoperatorios
CO2019007810A2 (es) Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer
ES2602986T3 (es) Nuevas composiciones cosméticas y/o farmacológicas y sus aplicaciones
ES2661582T3 (es) Efecto antiinflamatorio de la celulosa microfibrilada
CU20130007A7 (es) Pirimidinas y triazinas condensadas y su uso
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
DOP2016000109A (es) Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas.
DOP2014000043A (es) Pirimidinas anilladas sustituidas y uso de las mismas
ECSP088504A (es) Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopáusicos
MD20150085A2 (ro) Inhibitori ai histon-demetilazelor
EA201690964A1 (ru) Композиции и способы для уменьшения серьезных неблагоприятных сердечно-сосудистых явлений
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
GT201300080A (es) Proceso de elaboracion para derivados de pirimidina
ES2494316T3 (es) Ingrediente activo novedoso en cicatrización y uso del mismo
UY35693A (es) Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso
UY29777A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.
CL2007002382A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel.
CL2012002887A1 (es) Combinación farmacéutica que comprende compuestos derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituida, compuestos derivados de n-(2-arilamino)arilsulfonamida y opcionalmente otros agentes farmacéuticos adicionales; kit faramacéutico; método de tratamiento; y su uso para el tratamiento o la profilaxis del cáncer.
CL2016000436A1 (es) Método para el tratamiento de la enfermedad fibrótica
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
GT200500266A (es) Nuevos derivados de pirimidina y su uso
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
AR079945A1 (es) Derivados de pirazina como inhibidores de glucogeno sintasa quinasa 3 (gsk3)
CL2008002545A1 (es) Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor.